The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.
Related Posts
Private payroll growth slowed to 62,000 in April, well below expectations
Companies slowed hiring sharply in April as they braced against potential impacts from President Donald Trump’s tariffs.
Restaurant Brands reports 2.5% same-store sales growth, fueled by Burger King and Popeyes
Restaurant Brands’ revenue climbed 26% in the quarter.
DocuSign stock tanks 18% after company cuts billings outlook
The downbeat forecast overshadowed the company’s better-than-expected earnings and revenue results.